Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2018, Article ID 7927362, 4 pages
https://doi.org/10.1155/2018/7927362
Case Report

Sertoli-Leydig Cell Tumour and DICER1 Mutation: A Case Report and Review of the Literature

1St George’s Hospital, UK
2St George’s Hospital and the Royal Marsden Hospital, UK

Correspondence should be addressed to B. Wormald; ten.shn@dlamrow.neb

Received 20 June 2018; Accepted 6 September 2018; Published 25 September 2018

Academic Editor: Giampiero Capobianco

Copyright © 2018 B. Wormald et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Gui, D. Cao, K. Shen et al., “A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors,” Gynecologic Oncology, vol. 127, no. 2, pp. 384–389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. W. D. Foulkes, J. R. Priest, and T. F. Duchaine, “DICER1: mutations, microRNAs and mechanisms,” Nature Reviews Cancer, vol. 14, no. 10, pp. 662–672, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Doros, K. A. Schultz, D. R. Stewart, A. J. Bauer, G. Williams, C. T. Rossi et al., “DICER1-related disorders,” in GeneReviews(R). Seattle (WA): University of Washington, Seattle University of Washington, M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. H. Bean, and H. C. Mefford, Eds., Seattle University of Washington, Seattle, DC, USA, 2014. View at Google Scholar
  4. J. Kim, A. Field, K. A. P. Schultz, D. A. Hill, and D. R. Stewart, “The prevalence of DICER1 pathogenic variation in population databases,” International Journal of Cancer, vol. 141, no. 10, pp. 2030–2036, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Brenneman, A. Field, J. Yang et al., “Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model,” F1000Research, vol. 4, p. 214, 2015. View at Publisher · View at Google Scholar
  6. M. S. Anglesio, Y. Wang, W. Yang et al., “Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage,” The Journal of Pathology, vol. 229, no. 3, pp. 400–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. P. Schultz, A. K. Harris, M. Finch et al., “DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: clinical and genetic findings from the international ovarian and testicular stromal tumor registry,” Gynecologic Oncology, vol. 147, no. 3, pp. 521–527, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. L. De Kock, T. Terzic, W. G. McCluggage et al., “DICER1 mutations are consistently present in moderately and poorly differentiated sertoli-leydig cell tumors,” The American Journal of Surgical Pathology, vol. 41, no. 9, pp. 1178–1187, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Witkowski, J. Mattina, S. Schönberger et al., “DICER1 hotspot mutations in non-epithelial gonadal tumours,” British Journal of Cancer, vol. 109, no. 10, pp. 2744–2750, 2013. View at Publisher · View at Google Scholar
  10. Y. Wang, J. Chen, W. Yang et al., “The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors,” Neoplasia, vol. 17, no. 8, pp. 650–660, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. N. E. Khan, A. J. Bauer, K. A. P. Schultz, L. Doros, R. M. Decastro, and A. Ling, “Quantification of thyroid cancer and multinodular goiter risk in the DICER1 syndrome: a family-based cohort study,” The Journal of Clinical Endocrinology & Metabolism, vol. 102, no. 5, pp. 1614–1622, 2017. View at Publisher · View at Google Scholar
  12. K. A. P. Schultz, S. P. Rednam, J. Kamihara et al., “PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: Clinical features, genetics, and surveillance recommendations in childhood,” Clinical Cancer Research, vol. 23, no. 12, pp. e76–e82, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. K. van Engelen, A. Villani, J. D. Wasserman et al., “DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center,” Pediatric Blood & Cancer, vol. 65, no. 1, 2018. View at Google Scholar · View at Scopus
  14. D. G. Sabapathy, R. Paul Guillerman, R. C. Orth et al., “Radiographic screening of infants and young children with genetic predisposition for rare malignancies: DICER1 mutations and pleuropulmonary blastoma,” American Journal of Roentgenology, vol. 204, no. 4, pp. W475–W482, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. Bueno, C. Martínez-Ríos, A. D. la Puente Gregorio et al., “Pediatric imaging in DICER1 syndrome,” Pediatric Radiology, vol. 47, no. 10, pp. 1292–1301, 2017. View at Publisher · View at Google Scholar · View at Scopus